VITI, VITTORIO
 Distribuzione geografica
Continente #
EU - Europa 234
AS - Asia 164
NA - Nord America 131
SA - Sud America 56
AF - Africa 2
Totale 587
Nazione #
RU - Federazione Russa 132
US - Stati Uniti d'America 119
SG - Singapore 70
IT - Italia 55
BR - Brasile 50
CN - Cina 44
VN - Vietnam 23
FR - Francia 13
NL - Olanda 10
DE - Germania 8
HK - Hong Kong 8
MX - Messico 8
GB - Regno Unito 7
IN - India 6
CA - Canada 3
ID - Indonesia 3
AR - Argentina 2
BD - Bangladesh 2
DZ - Algeria 2
FI - Finlandia 2
IQ - Iraq 2
JP - Giappone 2
PL - Polonia 2
TR - Turchia 2
VE - Venezuela 2
AT - Austria 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
LB - Libano 1
PY - Paraguay 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
Totale 587
Città #
Singapore 46
Dallas 42
Moscow 20
San Jose 14
Ashburn 12
Beijing 10
Ho Chi Minh City 8
Hong Kong 7
Hanoi 6
Hefei 5
Lauterbourg 5
Santa Clara 5
São Paulo 5
Los Angeles 4
Milan 4
Orem 4
St Louis 4
Amsterdam 3
Bari 3
Brooklyn 3
Curitiba 3
Frankfurt am Main 3
Mexico City 3
Mont-le-Vignoble 3
Mumbai 3
New York 3
Vistarino 3
Alessandria 2
Assago 2
Bauru 2
Belo Horizonte 2
Caracas 2
Chicago 2
City of London 2
Da Nang 2
Denver 2
Houston 2
London 2
Montes Claros 2
Montreal 2
Munich 2
Nuremberg 2
Osasco 2
Phoenix 2
Querétaro 2
Reston 2
São Bernardo do Campo 2
Thái Bình 2
Turku 2
Vimodrone 2
Algiers 1
Alto Paraíso de Goiás 1
Ankara 1
Araguapaz 1
Araçatuba 1
Araçoiaba da Serra 1
Asunción 1
Baghdad 1
Blumenau 1
Boqueirão do Leão 1
Bratislava 1
Brighton 1
Cachoeirinha 1
Caibi 1
Candeias 1
Cascavel 1
Catalão 1
Caçador 1
Cedro 1
Chatham 1
Chennai 1
Contagem 1
Criciúma 1
Dhaka 1
Dossobuono 1
Duhok 1
Guadalajara 1
Guangzhou 1
Hyderabad 1
Ivinhema 1
Jacksonville 1
Kamensk-Uralsky 1
Kobe 1
Kouba 1
Lille 1
Londrina 1
Lấp Vò 1
Manchester 1
Manhuaçu 1
Mannheim 1
Marseille 1
Mauá 1
Montevideo 1
New Delhi 1
Palmares 1
Paragominas 1
Pittsburgh 1
Porto Alegre 1
Quanzhou 1
Quảng Ngãi 1
Totale 327
Nome #
Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use 131
Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS? 112
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 98
Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue 89
Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report 78
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab 72
Environmental risk factors and conversion to multiple sclerosis in subjects with radiologically isolated syndrome: a case–control study 31
Totale 611
Categoria #
all - tutte 1.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202573 0 7 4 2 0 2 8 4 6 5 17 18
2025/2026538 26 57 61 74 44 17 39 42 146 32 0 0
Totale 611